Sentences with phrase «including pharmaceutical marketing»

Not exact matches

You measure a country's ability to innovate using myriad factors, including registered trademarks, articles published in scientific journals and the size of its export market in fields like electronics or pharmaceuticals.

The healthcare titan has hundreds of subsidiaries and core operations that dominate attractive market segments including consumer goods, medical devices, and pharmaceuticals.

CVS Health is a pharmaceuticals and pharmacy services company that has offered remote jobs for openings including clinical pharmacist consultants, call center representatives, liquor marketing managers, and client support representatives.

Further, competitors, including Insys Therapeutics (NASDAQ: INSY), are developing their own CBD alternative medications to Epidiolex that could crimp GW Pharmaceuticals» market opportunity, too.

The company has been working with companies in various segments of the market in Canada and the United States, and its goals include aligning with current product and consumer trends and offering top - quality food ingredients to the food, pharmaceuticals and nutraceutical industries.

Best Label a privately - owned label manufacturer on the West Coast with facilities in Mexico and California, has purchased and installed the Epson SurePress L - 6034VW to expand its short - run label printing offerings for customers in several markets, including food, beverage, health, beauty, pharmaceutical, nutraceutical, sports, automotive, agricultural, and chemical manufacturing.

Key Features: • Focuses on health claim legislation for this commercially important food sector • Includes chapters on the current situation in all the major world markets including Europe, the USA, Japan, India and China • Covers food, feed and pharmaceutical applications of probiotics

Other markets for flexible packaging include retail non-food at 12 percent; industrial applications at 6 percent; consumer products at 10 percent; institutional non-food at 3 percent; and medical and pharmaceutical at 9 percent.

Brad has thirty years of experience bringing innovative products and ideas to market in a wide variety of industries, including pharmaceuticals, personal care products, ergonomic devices, and food.

For the pharmaceutical market, the Combination Carton includes a printed and folded insert into paperboard cartons, eliminating the need to add the leaflet separately on the packaging line.

These include limited access to quality mental health care, influences of a powerful health insurance industry and intensive marketing efforts by the pharmaceutical industry.

We are a crucial — profitable — export market for Europe's automotive industry, as well as sectors including energy, food and drink, chemicals, pharmaceuticals, and agriculture.

Before the FDA approved nusinersen, which is marketed by Biogen and Ionis Pharmaceuticals as Spinraza, the only care options were palliative care or supportive care, including physical therapy, respiratory help or assistive devices.

Gomes said there are several potential explanations for the provincial differences in high - dose opioid prescribing, including varying coverage among public drug plans, training among prescribers and differential marketing on the part of pharmaceutical companies.

The Food and Drug Administration is monitoring about 30 critical pharmaceuticals manufactured either solely or primarily on Puerto Rico — including 14 that can not be substituted by anything else on the market, FDA Commissioner Scott Gottlieb told a congressional panel yesterday.

These risks and uncertainties include, among others, those relating to our ability to obtain financing and to form collaborative relationships, uncertainty regarding potential future deterioration in the market for auction rate securities which could result in additional permanent impairment charges, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, the outcome of the review of the continued listing of our common stock on The Nasdaq Stock Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

This report is intended for all the stakeholders of the antiaging market, including drug and supplement companies, cosmetic companies, pharmaceutical (pharma) and health care, biotech companies, medspa companies, physical fitness companies, and nutrition companies.

India About Blog RNRMarketresearch.com provides a variety of market research reports in a variety of industries including telecommunication, healthcare and pharmaceutical, financial services, energy, technology, real estate, logistics, food and beverages and media.

The NASDAQ Biotechnology Index is a modified capitalization weighted index that includes NASDAQ Stock Market listed companies that are classified as either biotechnology or pharmaceutical.

This segment serves multiple markets including child - training pants and diapers, pharmaceutical packaging, food & beverage packaging, furniture and electronics.

Benefits include: back office, marketing, and scheduling support; access to preferred pricing on supplies, pharmaceuticals, and vaccines; and more!

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Merck's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Merck's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.

Dave's experience includes start - up to Fortune 1000 companies, public and private companies, domestic and international, and includes experience in consumer and industrial markets, life science, pharmaceuticals and medical device companies, technology, real estate and banking and finance.

India About Blog RNRMarketresearch.com provides a variety of market research reports in a variety of industries including telecommunication, healthcare and pharmaceutical, financial services, energy, technology, real estate, logistics, food and beverages and media.

This is significantly lower than what other industries, including pharmaceutical and finance companies, spend on marketing, according to marketing research companies.

Mirena was introduced to market in 2000, but in 2009, the FDA warned its manufacturer, Bayer Pharmaceuticals, that Mirena advertising «presents unsubstantiated claims, minimizes the risks of using Mirena, and includes false or misleading presentations regarding Mirena».

Career highlights include defending a director prosecuted in the largest direct tax prosecution ever conducted by CPS Revenue & Customs Division; advising a range of individuals involved in the US / UK investigations into the alleged manipulation of the foreign exchange market and the LIBOR / EURIBOR rate; pursuing an appeal against a sentence to the European Court of Human Rights; and conducting an internal investigation on behalf of a pharmaceutical company.

With respect to his life sciences practice, Mr. Bauer regularly advises pharmaceutical and biotechnology clients on a range of transactional matters, including complex licensing arrangements, product and intellectual property acquisition agreements, research and development collaborations, commercialization agreements, marketing and co-promotion agreements and supply and distribution arrangements.

Jon has served on national teams in numerous pharmaceutical and device mass torts handling trials along with discovery and strategy issues including science, sales, marketing and drug safety.

Our multidisciplinary team has extensive experience in complex regulatory and corporate matters, including middle market mergers and acquisitions for pharmaceutical and medical supply companies, senior living facilities, and institutional and group providers.

A global pharmaceutical company on its market entry into China including obtaining relevant licence and setting up a compliance program, establishing its branch company in China and preparing and submitting the legal documents for the registration with the local authorities.

Our pharmaceutical work puts us at the forefront of cutting edge issues, including preemption of medical device and prescription drug claims, the learned intermediary doctrine, comment k, market share liability, and brand name liability for generic use.

Acquisition finance; Banking litigation: investment and retail; Commercial litigation; Commercial property; Corporate crime (including fraud, bribery and corruption); Employment: employers; Equity capital markets; Financial services; Fraud: civil; Investment funds; Intellectual property; Investment funds; Pharmaceuticals and biotechnology; Power (including electricity, nuclear and renewables); Private equity: transactions; Professional negligence; Property finance; Securitisation; Tax litigation and investigations; Trade finance.

We have deep expertise advising medical device, pharmaceutical and biotechnology companies to compliantly get their products onto markets across Europe and on the full breadth of legal services including transactional work, regulatory advice, IP protection and enforcement services and dispute resolution.

His primary areas of practice include the energy and pharmaceutical markets.»

The suspended patent law provisions include those relating to patentable subject matter, and those providing patent term adjustments to compensate for unreasonable delays in patent issuance and unreasonable curtailment of the effective term of a pharmaceutical patent as a result of the marketing approval process.

Her matters have included grand jury and regulatory investigations, representing both companies and individuals in connection with allegations of insider - trading, commodities fraud, market manipulation and other securities fraud, foreign corrupt practices and pharmaceutical marketing violations.

Mr. Tantleff has worked with companies in a wide range of industries, including financial services, consulting, information technology, communications, consumer markets (retail, wholesale and distribution), life sciences, pharmaceuticals, health care and health services, manufacturing, media, technology, software development, automotive, transportation, energy, chemicals and utilities.

Riccardo Valle is a lawyer with our corporate team, focusing (in regards to transactional / litigation matters before Civil and Administrative Courts) in providing legal assistance to clients active in highly regulated markets, with specific focus on energy (including generation, infrastructures, incentives, PPA / EFET, and IPEX), environment (including waste, and EIA / IPPC), and pharmaceuticals (including AIFA regulations and wholesale distribution).

EEA's newest members represent a wide variety of business sectors, including technology, banking, government, healthcare, energy, pharmaceuticals, marketing, and insurance, as well as a number of fast - growing Ethereum startups.Composed of forward - looking enterprises and blockchain innovators, EEA is an industry - supported, non-profit established to build, promote, and broadly support Ethereum - based technology best practices, open standards, and open source reference architectures.

EEA's membership represents a wide variety of business sectors from every region of the world, including technology, banking, government, healthcare, energy, pharmaceuticals, marketing, logistics and insurance.

EEA's membership represents a wide variety of business sectors from every region of the world, including technology, banking, government, healthcare, energy, pharmaceuticals, marketing, and insurance, as well as a number of fast - growing Ethereum startups.

According to the consortium, which focuses on developments on the Ethereum blockchain, the newest members of EEA represent a «wide variety of business sectors, including technology, banking, government, healthcare, energy, pharmaceuticals, marketing, and insurance, as well as a number of fast - growing Ethereum startups.»

Hays Commercial Operations experts work with a number a multitude of Biotech's, CRO's, Pharmaceuticals and Strategic Consulting firms, while the jobs we offer to our candidates include both those at more junior levels such as Therapy Area Specialists jobs or Business Intelligence Analysts jobs, as well as Marketing / Brand Directors jobs or Principal Consultants jobs.

Hays Life Sciences gives you access to the largest range of pharmaceutical quality assurance jobs in the market, including QA consultant jobs, validation engineer jobs and quality control technician jobs.

They are backed by proven success in preparing interview - generating resumes for job seekers from virtually every career field and industry (including engineering, high - tech, sales, retail, wholesale, logistics, healthcare, pharmaceuticals, marketing, entertainment, finance, law, science, insurance, and education — just to name a few).

Activities these professionals perform include attending conferences and other events, marketing new products, delivering presentations to pharmaceutical product teams, and converting academic information into accessible messages.